Literature DB >> 19946292

Bone: serotonin, leptin and the central control of bone remodeling.

Clifford J Rosen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19946292     DOI： 10.1038/nrrheum.2009.231

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

1.  Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth.

Authors:  Stuart J Warden; Alexander G Robling; Megan S Sanders; Michael M Bliziotes; Charles H Turner
Journal:  Endocrinology       Date:  2004-11-11       Impact factor: 4.736

2.  Glucocorticoid-induced osteoporosis.

Authors:  J D Adachi
Journal:  Osteoporos Int       Date:  2009-05       Impact factor: 4.507

3.  Serotonin rising--the bone, brain, bowel connection.

Authors:  Clifford J Rosen
Journal:  N Engl J Med       Date:  2009-03-05       Impact factor: 91.245

4.  Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass.

Authors:  P Ducy; M Amling; S Takeda; M Priemel; A F Schilling; F T Beil; J Shen; C Vinson; J M Rueger; G Karsenty
Journal:  Cell       Date:  2000-01-21       Impact factor: 41.582

5.  Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum.

Authors:  Vijay K Yadav; Je-Hwang Ryu; Nina Suda; Kenji F Tanaka; Jay A Gingrich; Günther Schütz; Francis H Glorieux; Cherie Y Chiang; Jeffrey D Zajac; Karl L Insogna; J John Mann; Rene Hen; Patricia Ducy; Gerard Karsenty
Journal:  Cell       Date:  2008-11-28       Impact factor: 41.582

6.  Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice.

Authors:  Mathieu Ferron; Eiichi Hinoi; Gerard Karsenty; Patricia Ducy
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-24       Impact factor: 11.205

Review 7.  Medication-induced osteoporosis.

Authors:  Meng-Yi Weng; Nancy E Lane
Journal:  Curr Osteoporos Rep       Date:  2007-12       Impact factor: 5.096

8.  Fuller Albright. His concept of postmenopausal osteoporosis and what came of it.

Authors:  A P Forbes
Journal:  Clin Orthop Relat Res       Date:  1991-08       Impact factor: 4.176

9.  A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure.

Authors:  Vijay K Yadav; Franck Oury; Nina Suda; Zhong-Wu Liu; Xiao-Bing Gao; Cyrille Confavreux; Kristen C Klemenhagen; Kenji F Tanaka; Jay A Gingrich; X Edward Guo; Laurence H Tecott; J John Mann; Rene Hen; Tamas L Horvath; Gerard Karsenty
Journal:  Cell       Date:  2009-09-04       Impact factor: 41.582

10.  Associations between low levels of serum estradiol, bone density, and fractures among elderly women: the study of osteoporotic fractures.

Authors:  B Ettinger; A Pressman; P Sklarin; D C Bauer; J A Cauley; S R Cummings
Journal:  J Clin Endocrinol Metab       Date:  1998-07       Impact factor: 5.958
  10 in total
  5 in total

1.  An age-dependent interaction with leptin unmasks ghrelin's bone-protective effects.

Authors:  Martijn van der Velde; Bram C J van der Eerden; Yuxiang Sun; Julia M M Almering; Aart-Jan van der Lely; Patric J D Delhanty; Roy G Smith; Johannes P T M van Leeuwen
Journal:  Endocrinology       Date:  2012-06-14       Impact factor: 4.736

2.  Lean mass predicts hip geometry in men and women with non-insulin-requiring type 2 diabetes mellitus.

Authors:  Kendall F Moseley; Devon A Dobrosielski; Kerry J Stewart; Deborah E Sellmeyer; Suzanne M Jan De Beur
Journal:  J Clin Densitom       Date:  2011-06-11       Impact factor: 2.617

3.  Dietary tryptophan manipulation reveals a central role for serotonin in the anabolic response of appendicular skeleton to physical activity in rats.

Authors:  Valeria Sibilia; Francesca Pagani; Elisa Dieci; Emanuela Mrak; Marcella Marchese; Guido Zarattini; Francesca Guidobono
Journal:  Endocrine       Date:  2013-04-26       Impact factor: 3.633

Review 4.  The complex interplay of depression and falls in older adults: a clinical review.

Authors:  Andrea Iaboni; Alastair J Flint
Journal:  Am J Geriatr Psychiatry       Date:  2013-02-06       Impact factor: 4.105

5.  Combined structure-based pharmacophore and 3D-QSAR studies on phenylalanine series compounds as TPH1 inhibitors.

Authors:  Liang Ouyang; Gu He; Wei Huang; Xiangrong Song; Fengbo Wu; Mingli Xiang
Journal:  Int J Mol Sci       Date:  2012-05-02       Impact factor: 6.208
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.